Surgery remains the cornerstone of treatment for primary retroperitoneal sarcoma, aiming for complete en bloc resection to maximize disease clearance despite frequent tumor recurrence.
This review highlights that while complete en bloc resection is the cornerstone of treatment for retroperitoneal sarcoma, recurrence remains a significant challenge requiring multidisciplinary management.
Surgery is the cornerstone of treatment for retroperitoneal sarcoma (RPS). Surgery should be performed by a surgical oncologist with sub-specialization in this disease and in the context of a multidisciplinary team of sarcoma specialists. For primary RPS, the goal of surgery is to achieve the complete en bloc resection of the tumor along with involved organs and structures to maximize the clearance of the disease. The extent of resection also needs to consider the risk of complications. Unfortunately, the overarching challenge in primary RPS treatment is that even with optimal surgery, tumor recurrence occurs frequently. The pattern of recurrence after surgery (e.g., local versus distant) is strongly associated with the specific histologic type of RPS. Radiation and systemic therapy may improve outcomes in RPS and there is emerging data studying the benefit of non-surgical treatments in primary disease. Topics in need of further investigation include criteria for unresectability and management of locally recurrent disease. Moving forward, global collaboration among RPS specialists will be key for continuing to advance our understanding of this disease and find more effective treatments.
Dominguez et al. (Sat,) conducted a review in Retroperitoneal sarcoma. Surgery was evaluated. Surgery remains the cornerstone of treatment for primary retroperitoneal sarcoma, aiming for complete en bloc resection to maximize disease clearance despite frequent tumor recurrence.